SECsense Logo

Vor Biopharma Inc. 8-K Report: December 26, 2024 Insights and Updates

$VOR
Form 8-K
Filed on: 2024-12-27
Source
Vor Biopharma Inc. 8-K Report: December 26, 2024 Insights and Updates

The extracted key information from the provided section of the financial report is as follows:

  1. Document Type: This report is an 8-K filing, which is typically used to disclose significant events that shareholders should know about.
  2. Company Identification:
  • Company Name: Vor Biopharma Inc.
  • CIK Number: 0001817229
  • SEC Central Index Key (CIK): This identifies the company in SEC filings.
  • IRS Employer Identification Number: 81-1591163
  1. Corporate Address:
  • Location: 100 Cambridgepark Drive, Suite 101, Cambridge, MA 02140
  • Contact Number: (617) 655-6580
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Stock Symbol: VOR
  • Stock Exchange: NASDAQ
  1. Filing Date: The report is dated December 26, 2024.
  2. Filing Context:
  • Period Covered: The report covers a specific date, December 26, 2024.
  • Duration Context: The context ID indicates the reporting duration, but in this case, the date is a single day.
  1. Schema Reference: The report references a schema file named "vor-20241226.xsd" indicating the structure of the data contained in the filing.

Insights:

  • The filing indicates an important event or update from Vor Biopharma Inc. that required disclosure to investors.
  • The company's stock is traded on NASDAQ, which is relevant for investors tracking its performance.
  • The low par value of the common stock may suggest a focus on growth and reinvestment rather than high dividend payouts.
  • The specific date of the report may correlate with significant corporate actions or market conditions, which should be investigated in the context of the full report.

This information is crucial for investors, analysts, and stakeholders who are monitoring Vor Biopharma Inc.’s performance and corporate governance.